☆ 4.6 Editorial Material

Is the Harm-to-Benefit Ratio a Key Criterion in Vaccine Approval?

FRONTIERS IN MEDICINE (2022)

Get Full Text
Add to Collection

Journal

FRONTIERS IN MEDICINE
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2022.879120

Keywords

pivotal clinical trial; vaccination; SARS-CoV-2; severe adverse event; severe COVID-19 case

Categories

Medicine, General & Internal

Funding

  1. Open Access Fund of the University of Koblenz-Landau

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.